Showing results (371-380 of 652) with videos related to

Sort By:
Pageof 66
Journal of Clinical Lipidology|September 11, 2019
The use of structured data elements to identify ASCVD patients with statin-associated side effects: Insights from the Department of Veterans AffairsSalim S Virani, Julia M Akeroyd, Sarah T Ahmed, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 2, 2022
Trends, predictors, and outcomes of transcatheter aortic valve implantation in patients with bicuspid aortic valve related disease: Insights from the Nationwide Inpatient Sample and Nationwide Readmission DatabaseWaqas Ullah, Salman Zahid, Hamza Muhammadzai, et al.
Circulation. Cardiovascular Quality and Outcomes|August 30, 2021
Cardiovascular Disease Risk-Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care NetworkAnum Saeed, Jianhui Zhu, Floyd Thoma, et al.
American Journal of Preventive Medicine|July 7, 2021
Prevalence and Determinants of Difficulty in Accessing Medical Care in U.S. AdultsMahmoud Al Rifai, Dhruv Mahtta, Riyad Kherallah, et al.
Neurology|May 3, 2019
ApoB, small-dense LDL-C, Lp(a), LpPLA2 activity, and cognitive changeYashashwi Pokharel, Farah Mouhanna, Vijay Nambi, et al.
The American Journal of Cardiology|February 28, 2015
Coronary artery disease performance measures and statin use in patients with recent percutaneous coronary intervention or recent coronary artery bypass grafting (from the NCDR PINNACLE registry)Salman J Bandeali, Kensey Gosch, Mahboob Alam, et al.
Investigative Ophthalmology & Visual Science|August 18, 2025
Elevated PRDM13 Disrupts Photoreceptor Function and Survival in the Mammalian RetinaEmily R Nettesheim, Ashley A Rowe, Tiffany Yee, et al.
Journal of the American College of Cardiology|January 20, 2010
Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) studyEric Y Yang, Vijay Nambi, Zhengzheng Tang, et al.
Cardiovascular Drugs and Therapy|September 4, 2020
Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare SystemAkash Kataruka, Dhruv Mahtta, Julia M Akeroyd, et al.
Journal of General Internal Medicine|April 4, 2018
Impact of Patient-Centered Medical Home Implementation on Diabetes Control in the Veterans Health AdministrationLeChauncy D Woodard, Omolola E Adepoju, Amber B Amspoker, et al.
Pageof 66